Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berinert in acute HAE attacks (IMPACT-1)
NCT00168103Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Jun 2005
- Primary completion
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 15
01
Overview
A Phase 3 trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by CSL Limited. Started Jun 2005; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT00168103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168103.